Examples: ICD M32, ICD R6521, ICD 8210, ICD 1970

Z511 - ICD 10 Diagnosis Code - Encounter for antineoplastic chemotherapy and immunotherapy - Market Size, Prevalence, Incidence, Quality Outcomes, Top Hospitals & Physicians


Want to know more about Dexur's Capabilities? Get In Touch


ICD Code Description
Z5111 Encounter for antineoplastic chemotherapy
Z5112 Encounter for antineoplastic immunotherapy

Hospitalizations with Z511 - Encounter for antineoplastic chemotherapy and immunotherapy - as a primary diagnosis code

  |  Back to Top

*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.

ICD Code ICD Description Total National Projected Hospitalizations - Annualized (Present on Admission - All) Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) Total Medicare Hospitalization after Exclusion Avg. LOS Readmission Rate (%) Unplanned Readmission Rate (%) Total Medicare Payments Payment Per Day Payment Per Hospitalization Total Medicare Charges Avg. Charges Mortality Rate (%) SNF Discharge Rate (%) Home Discharge Rate (%)
Z5111 Encounter for antineoplastic chemotherapy 13.24
Z5112 Encounter for antineoplastic immunotherapy 10.41

Hospitalizations with Z511 - Encounter for antineoplastic chemotherapy and immunotherapy - as a primary or secondary diagnosis code

  |  Back to Top

*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.

ICD Code ICD Description Total National Projected Hospitalizations - Annualized (Present on Admission - All) Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) Total Medicare Hospitalization after Exclusion Avg. LOS Readmission Rate (%) Unplanned Readmission Rate (%) Total Medicare Payments Payment Per Day Payment Per Hospitalization Total Medicare Charges Avg. Charges Mortality Rate (%) SNF Discharge Rate (%) Home Discharge Rate (%)
Z5111 Encounter for antineoplastic chemotherapy 6.42 61.26
Z5112 Encounter for antineoplastic immunotherapy 5.64 54.38